Recent Company News

• 06:34 PM ET Feb 05, 2026
  

  Ascentage Pharma receives China CDE IND Clearance for BTK Degrader APG-3288 (HK$47.44, 0.00)

• 01:03 AM ET Feb 04, 2026
  

  StreetAccount Sector Summary - China Healthcare January Recap

• 09:11 PM ET Jan 15, 2026
  

  FDA grants orphan drug designation to lisaftoclax for treatment of Duchenne muscular dystrophy (HK$53.60, +0.20)

• 06:09 PM ET Jan 14, 2026
  

  Transcript Intelligence: Ascentage Pharma at J.P. Morgan Healthcare Conference (HK$54.50, 0.00)

• 04:54 PM ET Jan 13, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:55 AM ET Jan 13, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:04 AM ET Jan 13, 2026
  

  Rodman & Renshaw initiates AAPG, BCAB, BMEA, others

• 09:57 PM ET Jan 12, 2026
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 08:03 PM ET Jan 06, 2026
  

  Ascentage Pharma receives FDA IND clearance for BTK degrader APG-3288 (HK$51.50, 0.00)

• 01:59 AM ET Jan 05, 2026
  

  StreetAccount Sector Summary - China Healthcare December Recap